Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Evaluation of remibrutinib (LOU064) effectiveness and safety in adult patients with chronic urticaria: A 12-week placebo-controlled study

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Poland Spain
  • Study of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria

    Not recruiting

    2 1
    Investigated Diseases:
    Denmark Germany Italy Spain
  • Study on Long-Term Safety of Briquilimab for Patients with Chronic Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    France Germany Hungary Italy The Netherlands Poland +4
  • Study on Briquilimab for Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Germany